Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease

Science Advances(2025)10.1126/sciadv.ads3728Source: DataRank Database

Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease is a research paper published in Science Advances (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.48)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Chunzhang Cao,Vishnuprabu Durairaj Pandian ORCID,H Ye,Hongxia Chen ORCID,Li Zhang ORCID

Live enrichment

PubMed:40344054 PMC:PMC12063669 OpenAlex:https://openalex.org/W4410227688

NINDS NIH HHS

Grant: R01 NS110630

NHLBI NIH HHS

Grant: R01 HL142909

National Institutes of Health

Grant: 5R01HL142909-04

Targeting the Proinflammatory Activity of Integrin Mac-1 for Treatment of Atherosclerosis

National Institutes of Health

Grant: 5R01NS110630-02

Ligand-dependent and cell type-specific functions of integrin CD11b/CD18 in multiple sclerosis

FWCI

0.48

Citation Percentile

0.6%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.science.org/doi/pdf/10.1126/sciadv.ads3728?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.ads3728?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.ads3728

journalhttps://doi.org/10.1126/sciadv.ads3728

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40344054

Fields of Study

Immune Response and InflammationCell Adhesion Molecules ResearchImmune cells in cancer03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsAutoimmune DiseasesDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleImmune ToleranceMice, Inbred C57BLMonocytesMultiple SclerosisNitric OxideSignal TransductionMacrophage-1 AntigenMice, KnockoutMice

Keywords

Experimental autoimmune encephalomyelitisMultiple sclerosisImmunologyMyeloidImmunosuppressionAutoimmunityAutoimmune diseaseDiseaseNitric oxideInterferonMedicineBiologyCancer researchImmune systemAntibodyInternal medicineMice, KnockoutEncephalomyelitis, Autoimmune, ExperimentalMacrophage-1 AntigenMonocytesAutoimmune DiseasesMice, Inbred C57BLMiceDisease Models, AnimalImmune ToleranceAnimalsFemaleBiomedicine and Life SciencesSignal Transduction

Sustainable Development Goals

SDG 0: Good health and well-being

Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)